INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Point72 Asset Management, L.P.'s Holding History (CIK: 0001603466)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 166,300 Value ($000) $2,057 Avg Close Range
Q3 2022
Shares 1,559,183 Value ($000) $21,751 Avg Close Range
Q2 2022
Shares 127,300 Value ($000) $1,758 Avg Close Range
Q1 2022
Shares 76,500 Value ($000) $1,245 Avg Close Range
Q4 2021
Shares 514,200 Value ($000) $8,376 Avg Close Range
Q3 2021
Shares 698,700 Value ($000) $10,376 Avg Close Range
Q1 2019
Shares 648,278 Value ($000) $72,516 Avg Close Range
Q4 2018
Shares 80,200 Value ($000) $8,083 Avg Close Range
Q1 2018
Shares 281,900 Value ($000) $17,342 Avg Close Range
Q4 2017
Shares 27,500 Value ($000) $1,607 Avg Close Range
Q3 2017
Shares 57,500 Value ($000) $3,337 Avg Close Range
Q2 2017
Shares 285,600 Value ($000) $34,578 Avg Close Range
Q1 2017
Shares 220,600 Value ($000) $24,950 Avg Close Range
Q4 2016
Shares 195,100 Value ($000) $21,198 Avg Close Range
Q1 2016
Shares 10,300 Value ($000) $1,323 Avg Close Range
Q1 2015
Shares 132,300 Value ($000) $37,311 Avg Close Range
Q4 2014
Shares 300,200 Value ($000) $46,831 Avg Close Range
Q3 2014
Shares 37,300 Value ($000) $8,829 Avg Close Range
Q2 2014
Shares 26,500 Value ($000) $6,271 Avg Close Range